|
|
|
Volumn 8, Issue 2, 1994, Pages 431-450
|
|
Liposomal anthracyclines
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANNAMYCIN;
ANTHRACYCLINE DERIVATIVE;
CARDIOLIPIN;
CHOLESTEROL;
DAUNORUBICIN;
DOXORUBICIN;
DOXORUBICIN DERIVATIVE;
DOXORUBICINOL;
DRUG CARRIER;
EPIRUBICIN;
GLYCOLIPID;
LIPOSOME;
MACROGOL;
MITOXANTRONE;
OCTADECYLAMINE;
PHOSPHATIDIC ACID;
PHOSPHATIDYLCHOLINE;
PHOSPHATIDYLETHANOLAMINE;
PHOSPHATIDYLGLYCEROL;
PHOSPHOLIPID;
PLASMA PROTEIN;
ANTINEOPLASTIC ACTIVITY;
BLOOD CELL;
BLOOD TOXICITY;
BONE MARROW SUPPRESSION;
CANCER CHEMOTHERAPY;
CLINICAL TRIAL;
DRUG BLOOD LEVEL;
DRUG CLEARANCE;
DRUG DELIVERY SYSTEM;
DRUG DISTRIBUTION;
DRUG HALF LIFE;
DRUG RESISTANCE;
GASTROINTESTINAL SYMPTOM;
HEART FAILURE;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
MALIGNANT NEOPLASTIC DISEASE;
NONHUMAN;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
RETICULOENDOTHELIAL SYSTEM;
REVIEW;
STOMATITIS;
ANIMAL;
ANTIBIOTICS, ANTHRACYCLINE;
CLINICAL TRIALS;
DOXORUBICIN;
DRUG CARRIERS;
DRUG SCREENING ASSAYS, ANTITUMOR;
HUMAN;
LIPOSOMES;
SUPPORT, NON-U.S. GOV'T;
|
|
EID: 0028269637
PISSN: 08898588
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (117)
|
|
References (0)
|
